TOP 20 GLOBAL PRODUCTS 2014

RANK
GLOBAL MARKET
HUMIRA
LANTUS
SOVALDI
ABILIFY
ENBREL
SERETIDE
CRESTOR
REMICADE
NEXIUM
MABTHERA
AVASTIN
LYRICA
HERCEPTIN
SPIRIVA
JANUVIA
COPAXONE
NOVORAPID
NEULASTA
SYMBICORT
LUCENTIS

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

2014
SALES
(US$ Mn)

2014
GROWTH
(LC$ %)

2013
SALES
(US$ Mn)

936,511
11,844
10,331
9,375
9,285
8,707
8,652
8,473
8,097
7,681
6,552
6,070
6,002
5,564
5,483
4,991
4,788
4,718
4,627
4,535
4,437

8.8
22.1
30.4
13,262.2
19.2
11.0
-5.3
5.6
7.7
-1.4
4.3
6.4
19.0
7.2
4.8
14.0
2.8
17.1
5.5
18.9
2.2

879,631
9,784
8,014
70
7,824
7,918
9,198
8,140
7,648
7,867
6,363
5,793
5,107
5,261
5,283
4,457
4,691
4,071
4,397
3,885
4,382

Source: IMS Health MIDAS, December 2014

US$: Sales and Rank are in US$ with quarterly exchange rates
LC$: Growth is in constant $ to normalize for exchange rate fluctuations
Growth rates in US$ are not recommended due to fluctuations in the value of the dollar
Sales cover direct and indirect pharmaceutical channel wholesaler and manufacturers
The figures above include prescription and certain over the counter data and represent manufacturer prices
Product names shown are IMS International Product names.
Products marketed around the world with different names or marketing companies are grouped together
The names generally reflect the name in the country where the product was first launched
A match on two of three criteria (local brand name, marketing corporation and active ingredient) will be
grouped together

IMS Health HQ Limited

Registered Office: 210 Pentonville Road,
London N1 9JY, UK
Registered in England and Wales, Reg. No. 3614620

210 Pentonville Road

London N1 6JY
United Kingdom